We postulate that the co-stimulatory signaling of CD2-CD58, inducing T cell activation and hormone-sensitive lipase inactivation, might constitute one of the potential mechanisms contributing to the comorbidity of UC and MASLD. Here, CD2 is linked to metabolic dysfunction-associated steatotic liver disease.